Patents by Inventor Chandra Patterson

Chandra Patterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030207318
    Abstract: The invention provides a human kinesin-like motor protein (KLIMP) and polynucleotides which identify and encode KLIMP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of KLIMP.
    Type: Application
    Filed: June 9, 2003
    Publication date: November 6, 2003
    Applicant: Incyte Corporation
    Inventors: Y. Tom Tang, Neil C. Corley, Karl J. Guegler, Chandra Patterson
  • Publication number: 20030203396
    Abstract: The invention provides human galactosyltransferases (HUGA) and polynucleotides which identify and encode HUGA. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HUGA.
    Type: Application
    Filed: June 10, 2003
    Publication date: October 30, 2003
    Applicant: Incyte Corporation
    Inventors: Jennifer L. Hillman, Karl J. Guegler, Neil C. Corley, Purvi Shah, Chandra Patterson
  • Patent number: 6632636
    Abstract: The present invention provides the genomic sequences of a library of purified nucleic acid molecules, or their complements, comprising the genome of Moraxella catarrhalis. The invention also provides the identification of open reading frames contained within the nucleic acid molecules of the library. The present invention further provides for the use of the nucleic acid molecules, their complements or fragments, and proteins or portions thereof for identifying ligands and useful diagnostic and therapeutic compositions. In addition the invention provides for vectors, host cells and methods for producing M. catarrhalis proteins or portions thereof.
    Type: Grant
    Filed: June 16, 2000
    Date of Patent: October 14, 2003
    Assignee: Elitra Pharmaceuticals Inc.
    Inventors: Robert E. Lagace, Chandra Patterson, Kim L. Berg
  • Publication number: 20030166199
    Abstract: The invention provides a human serine dehydratase homolog (SDHH) and polynucleotides which identify and encode SDHH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of SDHH.
    Type: Application
    Filed: August 8, 2001
    Publication date: September 4, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Preeti Lal, Neil C. Corley, Karl J. Guegler, Chandra Patterson
  • Patent number: 6590089
    Abstract: The invention provides a mammalian cDNA which encodes a mammalian an RVP-1 variant. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of Crohn's disease. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Grant
    Filed: June 22, 2000
    Date of Patent: July 8, 2003
    Assignee: Incyte Genomics, Inc.
    Inventors: Lynn E. Murry, Jennifer L. Hillman, Y. Tom Tang, Chandra Patterson
  • Publication number: 20030124113
    Abstract: The invention provides human apoptosis associated proteins (HAPOP) and polynucleotides which identify and encode HAPOP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HAPOP.
    Type: Application
    Filed: December 23, 1999
    Publication date: July 3, 2003
    Inventors: JENNIFER L. HILLMAN, NEIL C. CORLEY, KARL J. GUEGLER, CHANDRA PATTERSON, MARIAH R. BAUGHN
  • Publication number: 20030113844
    Abstract: The invention provides a human delayed rectifier potassium channel subunit (DRPCS) and polynucleotides which identify and encode DRPCS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of DRPCS.
    Type: Application
    Filed: July 30, 2002
    Publication date: June 19, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Chandra Patterson, Neil C. Corley
  • Publication number: 20030109451
    Abstract: The invention provides a human arsenite-resistance protein (NITE) and polynucleotides which identify and encode NITE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of NITE.
    Type: Application
    Filed: December 2, 2002
    Publication date: June 12, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Neil C. Corley, Chandra Patterson
  • Publication number: 20030095960
    Abstract: The invention provides three human transferases (HUTRAN) and polynucleotides which identify and encode HUTRAN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HUTRAN.
    Type: Application
    Filed: October 29, 2002
    Publication date: May 22, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Preeti Lal, Olga Bandman, Jennifer L. Hillman, Karl J. Guegler, Gina A. Gorgone, Neil C. Corley, Chandra Patterson
  • Publication number: 20030087390
    Abstract: The invention provides human peptidyl-prolyl isomerases (HPPIP) and polynucleotides which identify and encode HPPIP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HPPIP.
    Type: Application
    Filed: October 9, 2002
    Publication date: May 8, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Preeti Lal, Neil C. Corley, Chandra Patterson, Mariah R. Baughn
  • Patent number: 6524838
    Abstract: The invention provides human peptidyl-prolyl isomerases (HPPIP) and polynucleotides which identify and encode HPPIP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HPPIP.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: February 25, 2003
    Assignee: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Preeti Lal, Neil C. Corley, Chandra Patterson, Mariah R. Baughn
  • Patent number: 6500642
    Abstract: The invention provides a mammalian cDNA which encodes a mammalian MAPOP-3. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of breast adenocarcinoma. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Grant
    Filed: June 22, 2000
    Date of Patent: December 31, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Henry Yue, Chandra Patterson, Neil C. Corley, Karl J. Guegler
  • Publication number: 20020182671
    Abstract: The invention provides human membrane associated proteins (MEMAP) and polynucleotides which identify and encode MEMAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of MEMAP.
    Type: Application
    Filed: September 26, 2001
    Publication date: December 5, 2002
    Inventors: Preeti Lal, Henry Yue, Y. Tom Tang, Olga Bandman, Neil Burford, Yalda Azimzai, Mariah R. Baughn, Dyung Aina M. Lu, Chandra Patterson
  • Publication number: 20020160488
    Abstract: The invention provides human GTPase-associated proteins (GPAP) and polynucleotides which identify and encode GPAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of GPAP.
    Type: Application
    Filed: April 9, 2002
    Publication date: October 31, 2002
    Applicant: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson
  • Patent number: 6471959
    Abstract: The invention provides three human transferases (HUTRAN) and polynucleotides which identify and encode HUTRAN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HUTRAN.
    Type: Grant
    Filed: January 21, 2000
    Date of Patent: October 29, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Preeti Lal, Olga Bandman, Jennifer L. Hillman, Karl J. Guegler, Gina A. Gorgone, Neil C. Corley, Chandra Patterson
  • Publication number: 20020156014
    Abstract: The invention provides human neurosecretory proteins (HUNSP) and polynucleotides which identify and encode HUNSP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HUNSP.
    Type: Application
    Filed: February 14, 2002
    Publication date: October 24, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Preeti Lal, Neil C. Corley, Chandra Patterson
  • Publication number: 20020146770
    Abstract: The invention provides seven human Ras proteins (RASP) and polynucleotides which identify and encode RASP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of RASP.
    Type: Application
    Filed: January 15, 2002
    Publication date: October 10, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Y. Tom Tang, Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson, Sajeev Batra, Mariah R. Baughn
  • Patent number: 6458575
    Abstract: The invention provides a human cyclophilin-type peptidyl-prolyl cis/trans isomerase (CPCI) and polynucleotides which identify and encode CPCI. The invention also provides expression vectors, host cells, antibodies, agonists, and antagnists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of CPCI.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: October 1, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Neil C. Corley, Karl J. Guegler, Chandra Patterson
  • Publication number: 20020127668
    Abstract: The invention provides a human kinesin-like motor protein (KLIMP) and polynucleotides which identify and encode KLIMP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of KLIMP.
    Type: Application
    Filed: May 2, 2001
    Publication date: September 12, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Y. Tom Tang, Neil C. Corley, Karl J. Guegler, Chandra Patterson
  • Patent number: 6432687
    Abstract: The invention provides a human delayed rectifier potassium channel subunit (DRPCS) and polynucleotides which identify and encode DRPCS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of DRPCS.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: August 13, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Chandra Patterson, Neil C. Corley